SCHEMBL6340206

SCHEMBL6340206

Cc1cc(Nc2ccccc2C(=O)O)n(-c2ccccn2)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 2/20 0.62
MAPT P10636 2/20 0.60
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
LMNA P02545 3/20 0.55
FTO Q9C0B1 2/20 0.53
PKM P14618 1/20 0.52
ALDH1A1 P00352 3/20 0.48
NPSR1 Q6W5P4 2/20 0.48
USP2 O75604 1/20 0.48
NTRK1 P04629 2/20 0.46
HPGD P15428 4/20 0.46
TSHR P16473 2/20 0.46
GAA P10253 2/20 0.46
KDM4E B2RXH2 1/20 0.43
MAPK1 P28482 2/20 0.43
IRAK4 Q9NWZ3 1/20 0.43
MYC P01106 1/20 0.42
AKR1B10 O60218 1/20 0.42
TRPA1 O75762 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6343631 0.90 MEN1 (0.52) GFERMAPTMEN1KMT2ALMNA
SCHEMBL6345124 0.89 MEN1 (0.56) GFERMAPTMEN1KMT2ALMNA
SCHEMBL6343392 0.88 KMT2A (0.61) GFERMAPTMEN1KMT2ALMNA
SCHEMBL6341341 0.87 MEN1 (0.54) GFERMAPTMEN1KMT2ALMNA
SCHEMBL6344686 0.86 KMT2A (0.53) GFERMAPTMEN1KMT2ALMNA
SCHEMBL6341582 0.86 KMT2A (0.56) GFERMAPTMEN1KMT2ALMNA
SCHEMBL6341693 0.86 GFER (0.63) GFERMAPTMEN1KMT2ALMNA
SCHEMBL6341254 0.86 KMT2A (0.48) GFERMAPTMEN1KMT2ALMNA
SCHEMBL6345140 0.86 GFER (0.62) GFERMAPTMEN1KMT2ALMNA
SCHEMBL7160064 0.86 GFER (0.46) GFERMAPTMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949648-B2 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-09-27 US disclosed
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1270572-A1 CONDENSED PYRAZOLE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND USE THEREOF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof PTGS1, PTGIS, IL5 GFER 2957/4885MAPT 3408/4885MEN1 4422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.